ING Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-864
| Closed | -$208K | – | 607 |
|
|
2025
Q4 | $208K | Buy |
+864
| New | +$221K | ﹤0.01% | 550 |
|
|
2024
Q2 | – | Sell |
-20,156
| Closed | -$3.99M | – | 612 |
|
|
2024
Q1 | $3.99M | Buy |
20,156
+7,019
| +53% | +$1.29M | 0.03% | 361 |
|
|
2023
Q4 | $2.26M | Sell |
13,137
-5,309
| -29% | -$816K | 0.02% | 394 |
|
|
2023
Q3 | $2.73M | Buy |
18,446
+2,257
| +14% | +$408K | 0.02% | 341 |
|
|
2023
Q2 | $3.54M | Sell |
16,189
-6,199
| -28% | -$1.38M | 0.03% | 297 |
|
|
2023
Q1 | $4.9M | Buy |
22,388
+58
| +0.3% | +$12.6K | 0.05% | 249 |
|
|
2022
Q4 | $4.65M | Buy |
+22,330
| New | +$4.91M | 0.05% | 242 |
|
|
2022
Q2 | – | Sell |
-5,701
| Closed | -$1.38M | – | 570 |
|
|
2022
Q1 | $1.38M | Sell |
5,701
-13,319
| -70% | -$3.22M | 0.01% | 432 |
|
|
2021
Q4 | $4.95M | Buy |
19,020
+6,803
| +56% | +$1.77M | 0.04% | 281 |
|
|
2021
Q3 | $3.22M | Buy |
12,217
+266
| +2% | +$72.7K | 0.04% | 263 |
|
|
2021
Q2 | $2.95M | Buy |
11,951
+2,317
| +24% | +$487K | 0.05% | 240 |
|
|
2021
Q1 | $1.87M | Buy |
9,634
+22
| +0.2% | +$4.41K | 0.04% | 264 |
|
|
2020
Q4 | $2.04M | Buy |
9,612
+6,405
| +200% | +$1.28M | 0.05% | 242 |
|
|
2020
Q3 | $550K | Buy |
3,207
+1,983
| +162% | +$366K | 0.02% | 285 |
|
|
2020
Q2 | $235K | Sell |
1,224
-14,412
| -92% | -$2.36M | 0.01% | 249 |
|
|
2020
Q1 | $2.3M | Buy |
+15,636
| New | +$2.49M | 0.1% | 127 |
|
|
2019
Q4 | – | Sell |
-8,950
| Closed | -$1.21M | – | 526 |
|
|
2019
Q3 | $1.21M | Buy |
8,950
+1,803
| +25% | +$236K | 0.03% | 274 |
|
|
2019
Q2 | $872K | Buy |
+7,147
| New | +$792K | 0.02% | 410 |
|
|
2019
Q1 | – | Sell |
-16,572
| Closed | -$1.89M | – | 805 |
|
|
2018
Q4 | $1.89M | Buy |
+16,572
| New | +$1.78M | 0.04% | 234 |
|
|
2018
Q2 | – | Sell |
-14,603
| Closed | -$1.44M | – | 833 |
|
|
2018
Q1 | $1.44M | Buy |
+14,603
| New | +$1.38M | 0.03% | 260 |
|
|
2017
Q4 | – | Sell |
-5,090
| Closed | -$392K | – | 874 |
|
|
2017
Q3 | $392K | Buy |
+5,090
| New | +$389K | 0.01% | 593 |
|
|
2016
Q2 | – | Sell |
-9,100
| Closed | -$526K | – | 589 |
|
|
2016
Q1 | $526K | Sell |
9,100
-157,367
| -95% | -$8.91M | 0.01% | 373 |
|
|
2015
Q4 | $8.94M | Buy |
+166,467
| New | +$9.38M | 0.05% | 251 |
|
|
2015
Q2 | – | Sell |
-84,757
| Closed | -$6.09M | – | 710 |
|
|
2015
Q1 | $6.09M | Buy |
84,757
+66
| +0.1% | +$4.29K | 0.03% | 361 |
|
|
2014
Q4 | $4.75M | Buy |
84,691
+11,257
| +15% | +$588K | 0.02% | 393 |
|
|
2014
Q3 | $3.62M | Sell |
73,434
-998
| -1% | -$50.8K | 0.02% | 394 |
|
|
2014
Q2 | $3.77M | Buy |
74,432
+7,073
| +11% | +$351K | 0.02% | 393 |
|
|
2014
Q1 | $3.01M | Buy |
+67,359
| New | +$3.03M | 0.02% | 430 |
|
Other funds holding RMD
VCM
VPM
DAM
ING Group's RMD Position: Q1 2026 in Review
ING Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 864 shares — an estimated $208K sold.
ING Group first reported a position in RMD in Q1 2014 and held it in 28 quarters. The position peaked at $8.94M in Q4 2015. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- ING Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
- ING Group sold 864 ResMed shares in Q1 2026, an estimated $208K.
- ING Group first reported a position in ResMed in Q1 2014 and held it in 28 quarters.
- ING Group's ResMed position peaked at $8.94M in Q4 2015.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on ING Group's 13F filing for Q1 2026, filed 11 May 2026.